Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Sodium Ascorbate (Biological Therapies) 30 g/100 mL injection, 100 mL bag |
has manufactured dose form |
False |
injection solution |
Inferred relationship |
Some |
|
Ascorbic Acid (DBL) 500 mg/5 mL injection, 5 mL ampoule |
has manufactured dose form |
False |
injection solution |
Inferred relationship |
Some |
|
Naloxone Min-I-Jet (CSL) 400 microgram/mL injection, syringe |
has manufactured dose form |
False |
injection solution |
Inferred relationship |
Some |
|
Lucentis 3 mg/0.3 mL injection, 0.3 mL vial |
has manufactured dose form |
False |
injection solution |
Inferred relationship |
Some |
|
Naloxone Hydrochloride (DBL) 400 microgram/mL injection, ampoule |
has manufactured dose form |
False |
injection solution |
Inferred relationship |
Some |
|
Lucentis 2.3 mg/0.23 mL injection, 0.23 mL vial |
has manufactured dose form |
False |
injection solution |
Inferred relationship |
Some |
|
Lucentis 1.65 mg/0.165 mL injection, 0.165 mL syringe |
has manufactured dose form |
False |
injection solution |
Inferred relationship |
Some |
|
Ultravist-300 62.34 g/100 mL (equivalent to 30 g/100 mL iodine) injection: solution, 100 mL vial |
has manufactured dose form |
False |
injection solution |
Inferred relationship |
Some |
|
Ultravist-370 76.88 g/100 mL (equivalent to 37 g/100 mL iodine) injection: solution, 100 mL vial |
has manufactured dose form |
False |
injection solution |
Inferred relationship |
Some |
|
Carbaccord 150 mg/15 mL injection, 15 mL vial |
has manufactured dose form |
False |
injection solution |
Inferred relationship |
Some |
|
Ultravist-240 24.94 g/50 mL (equivalent to 12 g/50 mL iodine) injection: solution, 50 mL vial |
has manufactured dose form |
False |
injection solution |
Inferred relationship |
Some |
|
Prohance 2.79 g/10 mL injection, 10 mL syringe |
has manufactured dose form |
False |
injection solution |
Inferred relationship |
Some |
|
Ultravist-300 6.234 g/10 mL (equivalent to 3 g/10 mL iodine) injection: solution, 10 mL vial |
has manufactured dose form |
False |
injection solution |
Inferred relationship |
Some |
|
Carboplatin (Hospira) 600 mg/60 mL injection, 60 mL vial |
has manufactured dose form |
False |
injection solution |
Inferred relationship |
Some |
|
Prohance 4.19 g/15 mL injection, 15 mL syringe |
has manufactured dose form |
False |
injection solution |
Inferred relationship |
Some |
|
Ultravist-370 23.066 g/30 mL (equivalent to 11.1 g/30 mL iodine) injection: solution, 30 mL vial |
has manufactured dose form |
False |
injection solution |
Inferred relationship |
Some |
|
Carboplatin (Novotech) 450 mg/45 mL injection, 45 mL vial |
has manufactured dose form |
False |
injection solution |
Inferred relationship |
Some |
|
Prohance 5.59 g/20 mL injection, 20 mL vial |
has manufactured dose form |
False |
injection solution |
Inferred relationship |
Some |
|
Ultravist-300 31.17 g/50 mL (equivalent to 15 g/50 mL iodine) injection: solution, 50 mL vial |
has manufactured dose form |
False |
injection solution |
Inferred relationship |
Some |
|
Carboplatin (Baxter) (carboplatin 150 mg / 15 mL) injection, 15 mL vial (trade product unit of use) |
has manufactured dose form |
False |
injection solution |
Inferred relationship |
Some |
|
Ultravist-300 93.51 g/150 mL (equivalent to 45 g/150 mL iodine) injection: solution, 150 mL vial |
has manufactured dose form |
False |
injection solution |
Inferred relationship |
Some |
|
Carboplatin (DBL) 150 mg/15 mL injection, 15 mL vial |
has manufactured dose form |
False |
injection solution |
Inferred relationship |
Some |
|
Ultravist-370 38.443 g/50 mL (equivalent to 18.5 g/50 mL iodine) injection: solution, 50 mL vial |
has manufactured dose form |
False |
injection solution |
Inferred relationship |
Some |
|
Neostigmine Methylsulfate (AstraZeneca) 500 microgram/mL injection, ampoule |
has manufactured dose form |
False |
injection solution |
Inferred relationship |
Some |
|
Prohance 4.19 g/15 mL injection, 15 mL vial |
has manufactured dose form |
False |
injection solution |
Inferred relationship |
Some |
|
Ultravist-370 56.665 g/75 mL (equivalent to 27.75 g/75 mL iodine) injection: solution, 75 mL vial |
has manufactured dose form |
False |
injection solution |
Inferred relationship |
Some |
|
Neostigmine Methylsulfate (AstraZeneca) 2.5 mg/mL injection, ampoule |
has manufactured dose form |
False |
injection solution |
Inferred relationship |
Some |
|
Carboplatin (Pfizer (Perth)) 150 mg/15 mL injection, 15 mL vial |
has manufactured dose form |
False |
injection solution |
Inferred relationship |
Some |
|
Ultravist-300 46.75 g/75 mL (equivalent to 22.5 g/75 mL iodine) injection: solution, 75 mL vial |
has manufactured dose form |
False |
injection solution |
Inferred relationship |
Some |
|
Carboplatin (Baxter) (carboplatin 450 mg / 45 mL) injection, 45 mL vial (trade product unit of use) |
has manufactured dose form |
False |
injection solution |
Inferred relationship |
Some |
|
Ultravist-370 15.377 g/20 mL (equivalent to 7.4 g/20 mL iodine) injection: solution, 20 mL vial |
has manufactured dose form |
False |
injection solution |
Inferred relationship |
Some |
|
Carbaccord 50 mg/5 mL injection, 5 mL vial |
has manufactured dose form |
False |
injection solution |
Inferred relationship |
Some |
|
Ultravist-300 12.47 g/20 mL (equivalent to 6 g/20 mL iodine) injection: solution, 20 mL vial |
has manufactured dose form |
False |
injection solution |
Inferred relationship |
Some |
|
Carbaccord 450 mg/45 mL injection, 45 mL vial |
has manufactured dose form |
False |
injection solution |
Inferred relationship |
Some |
|
Ultravist-370 153.77 g/200 mL (equivalent to 74 g/200 mL iodine) injection: solution, 200 mL bottle |
has manufactured dose form |
False |
injection solution |
Inferred relationship |
Some |
|
Ondansetron (Alphapharm) 8 mg/4 mL injection, 4 mL ampoule |
has manufactured dose form |
False |
injection solution |
Inferred relationship |
Some |
|
Paraldehyde (Phebra) 5 mL/5 mL injection, 5 mL ampoule |
has manufactured dose form |
False |
injection solution |
Inferred relationship |
Some |
|
Carboplatin (Baxter) 50 mg/5 mL injection, 5 mL vial |
has manufactured dose form |
False |
injection solution |
Inferred relationship |
Some |
|
Carboplatin (Pfizer (Perth)) 50 mg/5 mL injection, 5 mL vial |
has manufactured dose form |
False |
injection solution |
Inferred relationship |
Some |
|
Paraldehyde (Phebra) 5 mL/5 mL injection, 5 mL vial |
has manufactured dose form |
False |
injection solution |
Inferred relationship |
Some |
|
Carboplatin (DBL) 50 mg/5 mL injection, 5 mL vial |
has manufactured dose form |
False |
injection solution |
Inferred relationship |
Some |
|
Zofran 4 mg/2 mL injection, 2 mL syringe |
has manufactured dose form |
False |
injection solution |
Inferred relationship |
Some |
|
Carboplatin (Novotech) 50 mg/5 mL injection, 5 mL vial |
has manufactured dose form |
False |
injection solution |
Inferred relationship |
Some |
|
Citanest 3% with Octapressin 0.066 IU Dental injection, 2.2 mL cartridge |
has manufactured dose form |
False |
injection solution |
Inferred relationship |
Some |
|
Pethidine Hydrochloride (DBL) 75 mg/1.5 mL injection, 1.5 mL ampoule |
has manufactured dose form |
False |
injection solution |
Inferred relationship |
Some |
|
Onsetron 4 mg/2 mL injection, 2 mL ampoule |
has manufactured dose form |
False |
injection solution |
Inferred relationship |
Some |
|
Pethidine Hydrochloride (DBL) 25 mg/mL injection, ampoule |
has manufactured dose form |
False |
injection solution |
Inferred relationship |
Some |
|
Carboplatin (DBL) 450 mg/45 mL injection, 45 mL vial |
has manufactured dose form |
False |
injection solution |
Inferred relationship |
Some |
|
Citanest 3% with Octapressin 0.054 IU Dental injection, 1.8 mL cartridge |
has manufactured dose form |
False |
injection solution |
Inferred relationship |
Some |
|
Pethidine (AstraZeneca) 100 mg/2 mL injection, 2 mL ampoule |
has manufactured dose form |
False |
injection solution |
Inferred relationship |
Some |
|
Carboplatin (Novotech) 150 mg/15 mL injection, 15 mL vial |
has manufactured dose form |
False |
injection solution |
Inferred relationship |
Some |
|
Pethidine Hydrochloride (DBL) 50 mg/mL injection, ampoule |
has manufactured dose form |
False |
injection solution |
Inferred relationship |
Some |
|
Carboplatin (Pfizer (Perth)) 450 mg/45 mL injection, 45 mL vial |
has manufactured dose form |
False |
injection solution |
Inferred relationship |
Some |
|
Pethidine Hydrochloride (DBL) (pethidine hydrochloride 500 mg / 10 mL) injection, 10 mL vial (trade product unit of use) |
has manufactured dose form |
False |
injection solution |
Inferred relationship |
Some |
|
Isovue-300 612 mg (iodine 300 mg)/mL injection, 20 mL vial |
has manufactured dose form |
False |
injection solution |
Inferred relationship |
Some |
|
Carboplatin (Kabi) 450 mg/45 mL injection, 45 mL vial |
has manufactured dose form |
False |
injection solution |
Inferred relationship |
Some |
|
Isovue-200 408 mg (iodine 200 mg)/mL injection, 10 mL ampoule |
has manufactured dose form |
False |
injection solution |
Inferred relationship |
Some |
|
Pethidine Hydrochloride (DBL) 100 mg/2 mL injection, 2 mL ampoule |
has manufactured dose form |
False |
injection solution |
Inferred relationship |
Some |
|
Isovue-300 612 mg (iodine 300 mg)/mL injection, 100 mL vial |
has manufactured dose form |
False |
injection solution |
Inferred relationship |
Some |
|
Isovue-300 612 mg (iodine 300 mg)/mL injection, 10 mL ampoule |
has manufactured dose form |
False |
injection solution |
Inferred relationship |
Some |
|
Ondansetron (Kabi) 8 mg/4 mL injection, 4 mL ampoule |
has manufactured dose form |
False |
injection solution |
Inferred relationship |
Some |
|
Isovue-370 755 mg (iodine 370 mg)/mL injection, 150 mL vial |
has manufactured dose form |
False |
injection solution |
Inferred relationship |
Some |
|
Isovue-370 755 mg (iodine 370 mg)/mL injection, 50 mL vial |
has manufactured dose form |
False |
injection solution |
Inferred relationship |
Some |
|
Isovue-300 612 mg (iodine 300 mg)/mL injection, 70 mL vial |
has manufactured dose form |
False |
injection solution |
Inferred relationship |
Some |
|
Isovue-370 755 mg (iodine 370 mg)/mL injection, 70 mL vial |
has manufactured dose form |
False |
injection solution |
Inferred relationship |
Some |
|
Isovue-370 755 mg (iodine 370 mg)/mL injection, 200 mL vial |
has manufactured dose form |
False |
injection solution |
Inferred relationship |
Some |
|
Isovue-370 755 mg (iodine 370 mg)/mL injection, 20 mL vial |
has manufactured dose form |
False |
injection solution |
Inferred relationship |
Some |
|
Isovue-370 755 mg (iodine 370 mg)/mL injection, 30 mL vial |
has manufactured dose form |
False |
injection solution |
Inferred relationship |
Some |
|
Amikacin (DBL) 500 mg/2 mL injection, 2 mL vial |
has manufactured dose form |
False |
injection solution |
Inferred relationship |
Some |
|
Isovue-370 755 mg (iodine 370 mg)/mL injection, 100 mL vial |
has manufactured dose form |
False |
injection solution |
Inferred relationship |
Some |
|
Isovue-200 408 mg (iodine 200 mg)/mL injection, 20 mL vial |
has manufactured dose form |
False |
injection solution |
Inferred relationship |
Some |
|
Amikin (amikacin 500 mg / 2 mL) injection, 2 mL vial (trade product unit of use) |
has manufactured dose form |
False |
injection solution |
Inferred relationship |
Some |
|
Ondansetron (Claris) 8 mg/4 mL injection, 4 mL ampoule |
has manufactured dose form |
False |
injection solution |
Inferred relationship |
Some |
|
Ondansetron (Kabi) 4 mg/2 mL injection, 2 mL ampoule |
has manufactured dose form |
False |
injection solution |
Inferred relationship |
Some |
|
Influvac 2007 injection, 0.5 mL syringe |
has manufactured dose form |
False |
injection solution |
Inferred relationship |
Some |
|
Vaxigrip 2007 injection, 0.5 mL syringe |
has manufactured dose form |
False |
injection solution |
Inferred relationship |
Some |
|
Onsetron (ondansetron 8 mg / 4 mL) injection, 4 mL ampoule (trade product unit of use) |
has manufactured dose form |
False |
injection solution |
Inferred relationship |
Some |
|
Zofran 8 mg/4 mL injection, 4 mL syringe |
has manufactured dose form |
False |
injection solution |
Inferred relationship |
Some |
|
Ondansetron (RL) 8 mg/4 mL injection, 4 mL ampoule |
has manufactured dose form |
False |
injection solution |
Inferred relationship |
Some |
|
Ondaz 4 mg/2 mL injection, 2 mL ampoule |
has manufactured dose form |
False |
injection solution |
Inferred relationship |
Some |
|
Syntometrine injection, ampoule |
has manufactured dose form |
False |
injection solution |
Inferred relationship |
Some |
|
Lucrin 1 mg/0.2 mL injection, vial |
has manufactured dose form |
False |
injection solution |
Inferred relationship |
Some |
|
Navoban 5 mg/5 mL injection, 5 mL ampoule |
has manufactured dose form |
False |
injection solution |
Inferred relationship |
Some |
|
Navoban 2 mg/2 mL injection, 2 mL ampoule |
has manufactured dose form |
False |
injection solution |
Inferred relationship |
Some |
|
Tropisetron (AFT) 5 mg/5 mL injection, 5 mL ampoule |
has manufactured dose form |
False |
injection solution |
Inferred relationship |
Some |
|
Anzemet 12.5 mg/0.625 mL injection, 0.625 mL vial |
has manufactured dose form |
False |
injection solution |
Inferred relationship |
Some |
|
Xolair 75 mg/0.5 mL injection, 0.5 mL syringe |
has manufactured dose form |
False |
injection solution |
Inferred relationship |
Some |
|
Xolair 150 mg/mL injection, syringe |
has manufactured dose form |
False |
injection solution |
Inferred relationship |
Some |
|
Ferinject 100 mg/2 mL injection, 2 mL vial |
has manufactured dose form |
False |
injection solution |
Inferred relationship |
Some |
|
Retinofluor 500 mg/5 mL injection: solution, 5 mL vial |
has manufactured dose form |
False |
injection solution |
Inferred relationship |
Some |
|
Retinofluor 1.25 g/5 mL injection: solution, 5 mL vial |
has manufactured dose form |
False |
injection solution |
Inferred relationship |
Some |
|
Retinofluor 1 g/10 mL injection: solution, 10 mL vial |
has manufactured dose form |
False |
injection solution |
Inferred relationship |
Some |
|
Magnevist 7.035 g/15 mL injection, 15 mL vial |
has manufactured dose form |
False |
injection solution |
Inferred relationship |
Some |
|
Magnevist 9.38 g/20 mL injection, 20 mL syringe |
has manufactured dose form |
False |
injection solution |
Inferred relationship |
Some |
|
Ketoral 30 mg/mL injection, syringe |
has manufactured dose form |
False |
injection solution |
Inferred relationship |
Some |
|
Midazolam (Act) 15 mg/3 mL injection, 3 mL ampoule |
has manufactured dose form |
False |
injection solution |
Inferred relationship |
Some |
|
Midazolam (Act) 5 mg/mL injection, ampoule |
has manufactured dose form |
False |
injection solution |
Inferred relationship |
Some |
|
Midazolam (Act) 50 mg/10 mL injection, 10 mL ampoule |
has manufactured dose form |
False |
injection solution |
Inferred relationship |
Some |
|
Midazolam (Act) 5 mg/5 mL injection, 5 mL ampoule |
has manufactured dose form |
False |
injection solution |
Inferred relationship |
Some |
|
Glucose (Baxter) (in 1L bag) 50% (250 g/500 mL) injection, 500 mL bag |
has manufactured dose form |
False |
injection solution |
Inferred relationship |
Some |
|
Ubistesin Forte 4% / 1 in 100 000 injection, 1.7 mL cartridge |
has manufactured dose form |
False |
injection solution |
Inferred relationship |
Some |
|